Triglycerides ( TG ) were reduced in both groups ( P < 0.01 in metformin group ; P < 0.05 in repaglinide group ) , but total cholesterol ( TC ) and low-density lipoprotein ( LDL ) were decreased only after metformin treatment ( P < 0.05 ) .